Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Mevion Medical's $200 Million Funding Led by China Investors; Will Form China JV

publication date: Aug 4, 2015
Mevion Medical Systems, a Massachusetts company that makes proton therapy systems, announced a financing of up to $200 million led by two China Investors, HOPU Investments and YuanMing Capital. At the same time, Mevion and the two lead investors will form a China joint venture to produce, sell and service Mevion proton therapy systems in China. Joe Jachinowski, Mevion's CEO, told ChinaBio® Today in an email that the China JV will be funded by HOPU and YuanMing, over and above their contributions to the financing. Mevion will contribute its expertise to the JV, which will include helping the JV manufacture the machine in China. More details....

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

ChinaBio® Events

 

China Showcase 2020

San Francisco, USA

January 12, 2020

ChinaBio Partnering Forum 2020

Suzhou, China

May 6-7, 2020